Anti-erythropoietin antibody-mediated pure red cell aplasia after treatment with recombinant erythropoietin products: recommendations for minimization of risk. (Q50784833)
Jump to navigation
Jump to search
scientific article published in October 2004
Language | Label | Description | Also known as |
---|---|---|---|
English | Anti-erythropoietin antibody-mediated pure red cell aplasia after treatment with recombinant erythropoietin products: recommendations for minimization of risk. |
scientific article published in October 2004 |
Statements
Anti-erythropoietin antibody-mediated pure red cell aplasia after treatment with recombinant erythropoietin products: recommendations for minimization of risk. (English)
1 reference
Denis Cournoyer
1 reference
Edwin B Toffelmire
1 reference
George A Wells
1 reference
Dwayne L Barber
1 reference
Brendan J Barrett
1 reference
Robert Delage
1 reference
Donna L Forrest
1 reference
Raymonde F Gagnon
1 reference
Elizabeth A Harvey
1 reference
Pierre Laneuville
1 reference
Bruce J Patterson
1 reference
Man-Chiu Poon
1 reference
Gerald A Posen
1 reference
Hans A Messner
1 reference
Canadian PRCA Focus Group
1 reference
1 October 2004
1 reference
15
1 reference
10
1 reference
2728-2734
1 reference